Technicals

Why Earnings Season Could Be Great for Atlantica Yield (ABY)

Investors are always looking for stocks that are poised to beat at earnings season and Atlantica Yield plc ABY may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report. That is because Atlantica is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat […]

Stock Analysts

LeMaitre Vascular Buys Restore Flow Allografts for $14M

Leading developer, manufacturer, and marketer of medical devices for the treatment of peripheral vascular disease, LeMaitre Vascular, Inc. LMAT , announced the acquisition of Restore Flow Allografts – a leading organization dedicated in the research for restorative transplantation of donated human tissue (for medical treatment). The buyout is worth $14.0 million, of which $12.0 million has been paid at the closure of the deal […]

Stock Analysts

Pharma Stock Roundup: Pharma Stocks Rally on Trump Win, Pfizer to Divest Consumer Unit?

Although some big names like AstraZeneca AZN and Mylan MYL reported Q3 results this week, earnings reports were overshadowed by the run-up to the Presidential election and the surprise win of Donald Trump. In fact, the pharma sector responded favorably to Trump’s victory on hopes that there will be fewer drug pricing headwinds considering Trump was not as vocal as Hillary Clinton about rising drug prices and excessive price hikes. Trump’s pro-business stand is also expected to benefit the sector. […]

Stock Analysts

Coca-Cola European Partners (CCE) Beats Earnings in Q3

Coca-Cola European Partners plc or CCEP CCE reported better-than-expected results in the third quarter of 2016. Earnings of 74 cents (or €0.66) per share beat the Zacks Consensus Estimate of 72 cents by 2.8%. Earnings also improved 18.5% year over year on a pro forma comparable basis, excluding the impact of foreign exchange rate […]

Stock Analysts

5 Best Value Stocks with Low PEG Ratio

The popularity of value investing is growing by leaps and bounds, not just because of its appropriateness in the current market scenario, but mostly for the reason that it is one of the favorite investing mantras of billionaire investors. However, apparently simple to understand, this investing discipline has historically shown dangerous outcomes a number of times just because of people’s oversight of its basics. […]

Stock Analysts

Chemical Stocks’ Q3 Earnings to Watch on Nov 14: GSM, MBII

A couple of chemical companies are lined up to report their quarterly results on Nov 14. As per the Zacks Industry classification, the chemical industry is grouped under the broader Basic Materials sector. Based on the earnings scorecard as of Nov 9, earnings for the sector participants on the S&P 500 index that have already reported have increased 4.7% from the same period last year while revenues are down 3%. […]